A skeletal Class I relationship and a marked reduction in overjet were achieved in both treatment groups ; however , the duration of treatment was significantly shorter in the TFBC Group ( 0.45 years ) when compared with the Activator Group ( 1.37 years ) ( p < 0.001 ) .